EP2171059 - RNAI INHIBITION OF ALPHA-ENAC EXPRESSION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.03.2011 Database last updated on 18.11.2024 | Most recent event Tooltip | 18.03.2011 | Application deemed to be withdrawn | published on 20.04.2011 [2011/16] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2010/14] | Inventor(s) | 01 /
VAN HEEKE, Gino Novartis Horsham Research Centre Wimblehurst Road Horsham West Sussex Sussex RH12 5AB / GB | 02 /
HICKMAN, Emma Novartis Horsham Research Centre Wimblehurst Road Horsham West Sussex Sussex RH12 5AB / GB | 03 /
DANAHAY, Henry Luke Novartis Horsham Research Centre Wimblehurst Road Horsham West Sussex Sussex RH12 5AB / GB | 04 /
TAN, Pamela Kalte Marter 8 95326 Kulmbach / DE | 05 /
GEICK, Anke Holderlin-Anlage 12 95447 Bayreuth / DE | 06 /
VORNLOCHER, Hans-Peter Albert-Einstein-Ring 43a 95448 Bayreuth / DE | [2010/14] | Representative(s) | Spinner, David Richard Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
Former [2010/14] | Spinner, David Richard Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 08761002.8 | 13.06.2008 | [2010/14] | WO2008EP57476 | Priority number, date | EP20070110376 | 15.06.2007 Original published format: EP 07110376 | EP20070114265 | 13.08.2007 Original published format: EP 07114265 | [2010/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008152131 | Date: | 18.12.2008 | Language: | EN | [2008/51] | Type: | A2 Application without search report | No.: | EP2171059 | Date: | 07.04.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.12.2008 takes the place of the publication of the European patent application. | [2010/14] | Search report(s) | International search report - published on: | EP | 28.05.2009 | Classification | IPC: | C12N15/11, A61K31/713 | [2010/14] | CPC: |
C12N15/1138 (EP,KR,US);
A61K31/713 (EP,KR,US);
A61K45/06 (US);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P3/12 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/12 (EP);
C12N2310/14 (EP,KR,US);
C12N2310/315 (KR,US);
C12N2310/321 (EP,KR,US);
C12N2310/322 (KR,US);
C12N2310/351 (KR,US);
C12N2310/3513 (KR,US);
C12N2310/3515 (KR,US);
C12N2310/3521 (KR)
(-)
| C-Set: |
C12N2310/321, C12N2310/3521 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/14] | Extension states | AL | 15.01.2010 | BA | 15.01.2010 | RS | 15.01.2010 | Title | German: | RNAI-HEMMUNG DER ALPHA-ENAC-EXPRESSION | [2010/14] | English: | RNAI INHIBITION OF ALPHA-ENAC EXPRESSION | [2010/14] | French: | INHIBITION PAR ARNI DE L'EXPRESSION DU CANAL ALPHA-ENAC | [2010/14] | Entry into regional phase | 15.01.2010 | National basic fee paid | 15.01.2010 | Designation fee(s) paid | 15.01.2010 | Examination fee paid | Examination procedure | 15.01.2010 | Examination requested [2010/14] | 01.03.2010 | Amendment by applicant (claims and/or description) | 15.04.2010 | Despatch of a communication from the examining division (Time limit: M06) | 26.10.2010 | Application deemed to be withdrawn, date of legal effect [2011/16] | 29.11.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/16] | Divisional application(s) | EP10163496.2 / EP2224004 | EP10163498.8 / EP2224005 | EP10163499.6 / EP2223692 | EP10163500.1 / EP2223693 | EP10163501.9 / EP2223694 | EP10163502.7 / EP2223695 | Fees paid | Renewal fee | 11.06.2010 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] - LI TIANBO ET AL, "RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo.", AMERICAN JOURNAL OF PHYSIOLOGY. LUNG CELLULAR AND MOLECULAR PHYSIOLOGY APR 2006, (200604), vol. 290, no. 4, ISSN 1040-0605, pages L649 - L660, XP002509394 [X] 1-22 * the whole document * DOI: http://dx.doi.org/10.1152/AJPLUNG.00205.2005 | [A] - GRIESENBACH UTA ET AL, "Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo", RESPIRATORY RESEARCH, BIOMED CENTRAL LTD., LONDON, GB, (20060215), vol. 7, no. 1, ISSN 1465-9921, page 26, XP021013304 [A] * the whole document * DOI: http://dx.doi.org/10.1186/1465-9921-7-26 |